Compass Therapeutics, Inc.
CMPX
$5.28
$0.061.15%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.28% | -19.53% | -10.64% | -43.46% | 19.86% |
| Total Depreciation and Amortization | 1.09% | 0.82% | 1.39% | -22.80% | -0.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -67.59% | 4.84% | 29.07% | 2.50% | 37.73% |
| Change in Net Operating Assets | -56.64% | 863.34% | -85.30% | 219.85% | -740.04% |
| Cash from Operations | 8.31% | 10.42% | -44.16% | 17.09% | -2.76% |
| Capital Expenditure | -- | 100.00% | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,396.05% | -154.80% | -24.49% | -47.11% | 348.28% |
| Cash from Investing | -1,396.16% | -154.88% | -24.61% | -47.03% | 347.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | -748.96% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 200.00% | -300.00% |
| Cash from Financing | -- | 100.00% | -767.02% | -4,600.00% | -300.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 228.39% | -647.10% | -139.83% | -65.97% | 520.73% |